KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $19.7 billion.

  • Johnson & Johnson's Cash & Equivalents fell 1823.69% to $19.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.7 billion, marking a year-over-year decrease of 1823.69%. This contributed to the annual value of $19.7 billion for FY2025, which is 1823.69% down from last year.
  • Johnson & Johnson's Cash & Equivalents amounted to $19.7 billion in Q4 2025, which was down 1823.69% from $18.2 billion recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's Cash & Equivalents ranged from a high of $38.5 billion in Q1 2025 and a low of $10.5 billion during Q2 2022
  • Its 5-year average for Cash & Equivalents is $18.6 billion, with a median of $18.6 billion in 2025.
  • As far as peak fluctuations go, Johnson & Johnson's Cash & Equivalents crashed by 3549.76% in 2022, and later surged by 9287.08% in 2023.
  • Over the past 5 years, Johnson & Johnson's Cash & Equivalents (Quarter) stood at $17.6 billion in 2021, then plummeted by 35.5% to $11.4 billion in 2022, then soared by 92.51% to $21.9 billion in 2023, then grew by 10.27% to $24.1 billion in 2024, then fell by 18.24% to $19.7 billion in 2025.
  • Its last three reported values are $19.7 billion in Q4 2025, $18.2 billion for Q3 2025, and $18.6 billion during Q2 2025.